BlackRock Institutional Trust’s Endocyte, Inc. Common Stock ECYT Stock Holding History

BlackRock Institutional Trust’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.32M	Hold	517,159	–	–	﹤0.01%	3204
2016 Q3	$1.6M	Sell	517,159 -1,058	-0.2%	-$3.3K	﹤0.01%	3135
2016 Q2	$1.66M	Sell	518,217 -7,221	-1%	-$26.5K	﹤0.01%	3104
2016 Q1	$1.63M	Sell	525,438 -1,991	-0.4%	-$6.5K	﹤0.01%	3124
2015 Q4	$2.12M	Buy	527,429 +39,331	+8%	+$181K	﹤0.01%	3098
2015 Q3	$2.23M	Buy	488,098 +137,877	+39%	+$722K	﹤0.01%	3084
2015 Q2	$1.82M	Sell	350,221 -36,452	-9%	-$219K	﹤0.01%	3155
2015 Q1	$2.42M	Sell	386,673 -2,029	-0.5%	-$11.7K	﹤0.01%	3029
2014 Q4	$2.44M	Sell	388,702 -10,385	-3%	-$63.3K	﹤0.01%	3020
2014 Q3	$2.43M	Sell	399,087 -24,490	-6%	-$167K	﹤0.01%	2993
2014 Q2	$2.79M	Buy	423,577 +2,589	+0.6%	+$29.2K	﹤0.01%	3037
2014 Q1	$10M	Buy	420,988 +26,540	+7%	+$385K	﹤0.01%	2425
2013 Q4	$4.21M	Sell	394,448 -29,075	-7%	-$321K	﹤0.01%	2861
2013 Q3	$5.65M	Buy	423,523 +9,342	+2%	+$148K	﹤0.01%	2671
2013 Q2	$5.44M	Buy	+414,181	New	+$5.58M	﹤0.01%	2662

Other funds holding ECYT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock Institutional Trust's ECYT Position: Q4 2016 in Review

BlackRock Institutional Trust held its Endocyte, Inc. Common Stock (ECYT) position steady in Q4 2016 at 517,159 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #3204.

BlackRock Institutional Trust first reported a position in ECYT in Q2 2013 and has held it in 15 quarters since. The position peaked at $10M in Q1 2014. 96 funds tracked by Wall St. Rank hold ECYT as of Q4 2016.

BlackRock Institutional Trust held 517,159 shares of Endocyte, Inc. Common Stock worth $1.32M as of Q4 2016.
BlackRock Institutional Trust left its Endocyte, Inc. Common Stock share count unchanged in Q4 2016.
Endocyte, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3204 holding.
BlackRock Institutional Trust first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Endocyte, Inc. Common Stock position peaked at $10M in Q1 2014.
96 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.